# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-118079
Filing Date
2024-04-26
Accepted
2024-04-26 16:14:59
Documents
5
Period of Report
2024-06-11

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | d804494ddef14a.htm | DEF 14A | 777846
2 | GRAPHIC | g804494g01a01.jpg | GRAPHIC | 75596
3 | GRAPHIC | g804494g27m55.jpg | GRAPHIC | 641084
4 | GRAPHIC | g804494g62a93.jpg | GRAPHIC | 8723
5 | GRAPHIC | g804494g78i08.jpg | GRAPHIC | 654801
| Complete submission text file | 0001193125-24-118079.txt |  | 2663367

Mailing Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129
Business Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129 617-337-4680
Solid Biosciences Inc. (Filer) CIK: 0001707502 (see all company filings)

EIN.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38360 | Film No.: 24883936
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)